Literature DB >> 1437950

Parkinson's disease.

C D Marsden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1437950      PMCID： PMC2399392          DOI： 10.1136/pgmj.68.801.538

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  40 in total

1.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; J B Clark; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

2.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

Authors:  D G Graham
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

3.  Subcutaneous apomorphine in the treatment of Parkinson's disease.

Authors:  J P Frankel; A J Lees; P A Kempster; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  Aromatic amino acids and modification of parkinsonism.

Authors:  G C Cotzias; M H Van Woert; L M Schiffer
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

5.  Twin studies and the genetics of Parkinson's disease--a reappraisal.

Authors:  W G Johnson; S E Hodge; R Duvoisin
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

6.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

7.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

8.  Parkinson's disease: a disorder due to nigral glutathione deficiency?

Authors:  T L Perry; D V Godin; S Hansen
Journal:  Neurosci Lett       Date:  1982-12-13       Impact factor: 3.046

9.  A clinical and genetic study of familial Parkinson's disease.

Authors:  D M Maraganore; A E Harding; C D Marsden
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

10.  Success and problems of long-term levodopa therapy in Parkinson's disease.

Authors:  C D Marsden; J D Parkes
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321
View more
  2 in total

Review 1.  Drug treatment of Parkinson's disease in the 1990s. Achievements and future possibilities.

Authors:  A J Hughes
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 2.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.